Key result
A bacterial nanocellulose bio-prosthesis demonstrated significantly lower nucleotide conversion activities than native valves and displayed increased peripheral blood mononuclear cell adhesion.
Why the study?
Purinergic signalling pathways play a vital role in the biological functions of the aortic valve, but side-specific purinergic cascades across human, ovine, and novel bacterial nanocellulose bioprosthetic valves were not characterized.
Does a bacterial nanocellulose bio-prosthesis exhibit similar purinergic ecto-enzyme patterns compared to native aortic valves in an ovine model?
Observational
Does a bacterial nanocellulose bio-prosthesis exhibit similar purinergic ecto-enzyme patterns compared to native aortic valves in an ovine model?
Nucleotide-converting ecto-enzymes may serve as useful markers for evaluating the biological activity and cellularization of aortic valve prostheses.
May inform purinergic-targeted therapies in aortic stenosis; leaves open translational role of BNC prostheses.
Purinergic signalling pathways play a vital role in the biological functions of the aortic valve (AV) through nucleotide and adenosine-dependent receptor effects. This study focused on characterizing a side-specific purinergic cascade in human non-stenotic and stenotic AVs, ovine native AVs and a novel bacterial nanocellulose (BNC) bio-prosthesis in an ovine model. Human stenotic AVs were collected during replacement surgeries, while non-stenotic AVs came from heart transplant patients. Ovine native AVs were sourced from domestic sheep, and the BNC prosthesis was implanted in the ovine aorta for six months, with hemodynamic monitoring throughout. Biochemical assessments revealed a beneficial ecto-enzyme pattern in non-stenotic and native AVs, contrasting with a detrimental pattern in stenotic valves. The BNC prosthesis demonstrated significantly lower nucleotide conversion activities than native valves and displayed increased peripheral blood mononuclear cell adhesion on its aortic surface. These findings suggest that nucleotide-converting ecto-enzymes could serve as markers for the biological activity of AV prostheses, highlighting the need for further studies to enhance the cellularization of BNC prostheses, potentially through adenosine-releasing scaffold modifications.
No takes yet. Share an insight, caveat, or question.
Kutryb-Zając et al. (2025) conducted an observational in Aortic valve stenosis. Bacterial nanocellulose (BNC) bio-prosthesis and stenotic aortic valves vs. Native ovine aortic valves and non-stenotic human aortic valves was evaluated on Nucleotide conversion activities and ecto-enzyme patterns. A bacterial nanocellulose bio-prosthesis demonstrated significantly lower nucleotide conversion activities than native valves and displayed increased peripheral blood mononuclear cell adhesion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: